Operating Expenses
Impairment Charges
Analysis
StatementIncome Statement
SectionOperating Expenses
Metric ID:
impairment_chargesBusiness Segments
| Segment | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Life Sciences | $0 | $0 | $0 | $0 | $432M | — | — | $14M |
| Biotechnology | $13.5M | $13.5M | $13.5M | $0 | $15M | $0 | $86M | — |
| Biotechnology and Diagnostics | $19.25M | $19.25M | $19.25M | — | — | — | — | — |
| Diagnostics | $5.75M | $5.75M | $5.75M | $0 | — | — | — | — |
| Total | — | — | — | — | — | — | — | — |
Life Sciences, Biotechnology and Diagnostics Segment is derived from annual filings.
Biotechnology, Biotechnology and Diagnostics, Diagnostics, Life Sciences were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
